399 — Starcoin Share News
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
Brief: Innovative Pharmaceutical Biotech Enters MOU For Possible Acquisition Of A Company
Brief: Innovative Pharmaceutical Biotech Sees Net Loss Of HK$550 Mln To HK$600 Mln For FY25
Brief: Innovative Pharmaceutical Biotech Says To Allot And Issue 137.6 Million Shares
Brief: Innovative Pharmaceutical Biotech Announces Placing Of 206.4 Million Shares
Brief: Innovative Pharmaceutical Biotech Entered Into MoU With Conflux Hong Kong Management
Brief: Innovative Pharmaceutical Biotech Intends To Expand Its Business Into Blockchain Technology
Brief: Innovative Pharmaceutical Biotech Says Zhang Shen Is Appointed As An Executive Director
Brief: Innovative Pharmaceutical Biotech Says Li Jiehong Resigned As An Exec Director
Brief: Innovative Pharmaceutical Biotech's Unit And Terry Bio Pharmaceutical Co Enters Agency Agreement
Brief: Innovative Pharmaceutical Biotech Says Cheng Tak Yiu Resigned As An Executive Director
Brief: Innovative Pharmaceutical Biotech Says Li Jiehong Appointed As Executive Director
Brief: Innovative Pharmaceutical Biotech Posts H1 Revenue Of HKD3 Mln
Brief: Innovative Pharmaceutical Biotech Announces MoU For Possible Investment In Niraxx
Brief: Innovative Pharmaceutical Biotech Enters Into MoU On Possible Formation Of A Joint Venture
Brief: Innovative Pharmaceutical Biotech Posts FY Profit Attributable HK$103.4 Mln Versus Loss HK$245.7 Mln
Brief: Innovative Pharmaceutical Biotech Says Placing Agreement Announced On March 28 Has Lapsed
Brief: Innovative Pharmaceutical Biotech Shall Subscribe For Up To 114 Million Placing Shares
Brief: Innovative Pharmaceutical Biotech Posts HY Profit Attributable HK$193.7 Mln Versus Loss HK$115.7 Mln
Brief: Innovative Pharmaceutical Biotech Sees Profit Attributed For 6-months HK$100 Mln - HK$200 Mln